We are live on ! Find out more
PC

Pavadi Capital Portfolio holdings

AUM $81.2M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
-6.6%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$18.3M
Cap. Flow
-$11.5M
Cap. Flow %
-10.13%
Top 10 Hldgs %
52.42%
Holding
27
New
5
Increased
–
Reduced
20
Closed
2

Top Buys

Rank Stock Value
1
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$5.49M
2
AMN icon
AMN Healthcare
AMN
+$5.39M
3
INMD icon
InMode
INMD
+$5.34M
4
CYH icon
Community Health Systems
CYH
+$3.16M
5
COR icon
Cencora
COR
+$934K

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$7.41M
2
BAX icon
Baxter International
BAX
+$6.25M
3
ZBH icon
Zimmer Biomet
ZBH
+$5.89M
4
PHG icon
Philips
PHG
+$1.46M
5
MOH icon
Molina Healthcare
MOH
+$1.17M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
26
Baxter International
BAX
$13.5B
– –
-72,782
Closed -$6.25M
ZBH icon
27
Zimmer Biomet
ZBH
$18.2B
– –
-47,755
Closed -$5.89M
1
2

Similar funds

BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
AFG
Alterity Financial Group Bangor, Maine $69.9M AUM 40.65% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return

Pavadi Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Pavadi Capital held 27 positions worth $113M, down 14% from $132M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pavadi Capital withdrew a net $11.5M in Q1 2022, closing 2 positions and reducing 20 holdings. Its most notable exit was Baxter International, an estimated $6.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Pavadi Capital opened a new position in Syneos Health, Inc. Class A Common Stock worth $5.25M.

  • Pavadi Capital's largest Q1 2022 buy was Syneos Health, Inc. Class A Common Stock: 64,871 shares worth $5.25M.
  • Pavadi Capital's biggest Q1 2022 reduction was McKesson, cutting an estimated $7.41M.
  • Pavadi Capital fully exited Baxter International in Q1 2022, selling an estimated $6.25M.
  • Pavadi Capital's ten largest holdings make up 52% of its $113M portfolio in Q1 2022.
  • Pavadi Capital opened 5 new positions and closed 2 in Q1 2022.
  • Pavadi Capital's portfolio value fell 14% quarter-over-quarter to $113M.

Based on Pavadi Capital's 13F filing for Q1 2022, filed 16 May 2022.